Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec 11:2019:4289502.
doi: 10.1155/2019/4289502. eCollection 2019.

Trimethoprim-Sulfamethoxazole-Induced Aseptic Meningitis: A Rare Presentation of Commonly Used Antibiotic

Affiliations
Case Reports

Trimethoprim-Sulfamethoxazole-Induced Aseptic Meningitis: A Rare Presentation of Commonly Used Antibiotic

Salem Agabawi. Case Rep Infect Dis. .

Abstract

Drug-induced aseptic meningitis is a rare medical condition with trimethoprim-sulfamethoxazole being one of the most common antimicrobial agents associated with it. Here, I report a case of a 56-year-old male who presented to a health care facility with shock and meningitis-like syndrome in two occasions, one year apart following an exposure to trimethoprim-sulfamethoxazole for treatment of skin/soft tissue infection. Investigations did not reveal an infectious etiology in the two presentations. The patient improved with supportive care and withdrawal of the offending agent. In the two admissions, the patient improved following stopping the offending drug in addition to supportive care. The diagnosis of trimethoprim-sulfamethoxazole-induced aseptic meningitis was the most likely explanation for this case. Trimethoprim-sulfamethoxazole-induced aseptic meningitis is rare although it is a life-threatening side effect of TMP/SMX; therefore, the clinicians should keep the diagnosis of drug-induced aseptic meningitis in the differential diagnosis of aseptic meningitis in the appropriate clinical setting as early withdrawal of the culprit drug and supportive measurements will lead to early recovery.

PubMed Disclaimer

Conflict of interest statement

The author declares that there are no conflicts of interest.

References

    1. Parasuraman T. V., Frenia K., Romero J. Enteroviral meningitis. Pharmacoeconomics. 2001;19(1):3–12. doi: 10.2165/00019053-200119010-00001. - DOI - PubMed
    1. Connolly K. J., Hammer S. M. The acute aseptic meningitis syndrome. Infectious Disease Clinics of North America. 1990;4(4):599–622. - PubMed
    1. Junga Z., Theeler B., Singla M. Infliximab-induced aseptic meningitis in a patient with Crohn’s disease. ACG Case Reports Journal. 2018;5(1):p. e48. doi: 10.14309/crj.2018.48. - DOI - PMC - PubMed
    1. Simms K. M., Kortepeter C., Avigan M. Lamotrigine and aseptic meningitis. Neurology. 2012;78(12):921–927. doi: 10.1212/wnl.0b013e31824c4634. - DOI - PubMed
    1. Maniyar F., Rooney C., Lily O., Bazaz R. Anticonvulsant hypersensitivity syndrome presenting as aseptic meningitis. Journal of Neurology. 2009;256(7):1190–1191. doi: 10.1007/s00415-009-5089-3. - DOI - PubMed

Publication types

LinkOut - more resources